NBOMe compounds: a review of the evidence of use and harm
Review of the evidence of misuse and harm in relation to the NBOMe compounds.
Documents
Details
This paper reviews the evidence of misuse and harm in relation to the NBOMe compounds, which has been considered by ACMD at meetings of the Novel Psychoactive Substances Committee in April 2013 and by the full Council in May and October 2013.
Updates to this page
Published 28 November 2013Last updated 18 February 2014 + show all updates
-
Addendum to ACMD's NBOMe advice added.
-
First published.